Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.02260
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Monoclonal Gammopathy-Associated Thrombotic Microangiopathy

American Journal of Hematology
Hematology
2019English

Image Gallery: Relapsing Polychondritis Associated With Monoclonal Gammopathy

British Journal of Dermatology
DermatologyMedicine
2017English

Monoclonal Gammopathy of Undetermined Significance

English

Membranoproliferative Glomerulonephritis Secondary to Monoclonal Gammopathy

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2010English

Detection and Prevalence of Monoclonal Gammopathy of Undetermined Significance: A Study Utilizing Mass Spectrometry-Based Monoclonal Immunoglobulin Rapid Accurate Mass Measurement

Blood Cancer Journal
OncologyHematology
2019English

Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2015English

Transient Monoclonal Gammopathy in Hydralazine Induced Lupus Erythematosus.

BMJ
1983English

Transient Monoclonal Gammopathy Induced by DisseminatedStaphylococcus aureusInfection

Case Reports in Medicine
Medicine
2012English

Polyclonal Immunoglobulin Secretion in Patients With Common Variable Immunodeficiency Using Monoclonal B Cell Differentiation Factors.

Journal of Clinical Investigation
Medicine
1984English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy